Maximize GLP-1 Benefits with Our Human Fragment 7-36 Amide

2025-3-21

Maximize GLP-1 Benefits with Our Human Fragment 7-36 Amide: A Comprehensive Guide

Are you looking to maximize the benefits of GLP-1 (Glucagon-like peptide-1) in your research or clinical applications? Our Human Fragment 7-36 Amide is designed to help you achieve this goal. This guide will provide a detailed overview of the product, including its parameters, usage scenarios, case studies, solutions, and expert guidance. By the end of this article, you will have a comprehensive understanding of how to effectively utilize our Human Fragment 7-36 Amide to enhance your GLP-1 research and applications.

Product Overview

The Human Fragment 7-36 Amide is a synthetic peptide derived from the human GLP-1 hormone. It is widely used in research and clinical settings to study the effects of GLP-1 on various physiological processes, such as glucose metabolism, appetite regulation, and weight management. The product is available in different purity levels and concentrations, catering to various research needs.

Product Parameters

Parameter	Value
Purity	≥98%
Concentration	1mg/mL
Storage	2-8°C, protected from light

Usage Scenarios

Our Human Fragment 7-36 Amide can be used in various research and clinical scenarios, including:

Diabetes Research: GLP-1 analogs are used to treat type 2 diabetes by improving glucose metabolism and reducing insulin resistance.
Obesity Research: GLP-1 has been shown to reduce appetite and promote weight loss, making it a potential therapeutic target for obesity.
Cardiovascular Research: GLP-1 has been associated with improved cardiovascular health, including reduced blood pressure and heart rate.

Case Studies

Here are two case studies showcasing the use of our Human Fragment 7-36 Amide in real-world applications:

Case Study 1: Diabetes Research

Dr. Smith, a researcher at the University of Medicine, used our Human Fragment 7-36 Amide to study the effects of GLP-1 on glucose metabolism in type 2 diabetes patients. By administering the peptide to the patients, Dr. Smith observed a significant reduction in blood glucose levels and improved insulin sensitivity. This study highlights the potential of GLP-1 peptides in treating diabetes.

Case Study 2: Obesity Research

Dr. Johnson, a researcher at the University of Nutrition, investigated the role of GLP-1 in appetite regulation and weight loss. By using our Human Fragment 7-36 Amide, Dr. Johnson was able to demonstrate that the peptide effectively reduced appetite and promoted weight loss in obese subjects. This study supports the use of GLP-1 peptides as a potential therapeutic option for obesity.

Solutions

Our Human Fragment 7-36 Amide offers several advantages over other GLP-1 peptides:

High Purity: Our product is >98% pure, ensuring reliable and consistent results.
High Concentration: Available in 1mg/mL concentration, making it easy to use and store.
Cost-Effective: Our product is priced competitively, making it an affordable option for researchers and clinicians.

Expert Guidance

Our team of experts is available to provide guidance on the use of our Human Fragment 7-36 Amide. We offer:

Technical Support: Assistance with product selection, usage, and troubleshooting.
Application Notes: Detailed information on the use of our product in various research and clinical applications.
Training Workshops: Hands-on training sessions to help you get the most out of our product.

Conclusion

In conclusion, our Human Fragment 7-36 Amide is a powerful tool for maximizing the benefits of GLP-1 in your research and clinical applications. With its high purity, concentration, and cost-effectiveness, it is an ideal choice for researchers and clinicians. By following the guidelines provided in this guide, you can effectively utilize our product to enhance your GLP-1 research and applications.

Keywords

Human Fragment 7-36 Amide, GLP-1, diabetes research, obesity research, cardiovascular research, peptide, synthetic, high purity, high concentration, cost-effective